Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYP2B6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TXNDC12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YIPF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101927933 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929902 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HTR2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GJC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on